3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
17
Neoplasms
6
Pancreatic Neoplasms
5
Lung Neoplasms
4
Squamous Cell Carcinoma of Head and Neck
3
Head and Neck Neoplasms
3
Triple Negative Breast Neoplasms
1
Small Cell Lung Carcinoma
1
Salivary Gland Neoplasms
1
Rhabdoid Tumor
1
Respiratory Tract Diseases
1
Papillary renal cell carcinoma, sporadic
1
Pancreatic Intraductal Neoplasms
1
Oropharyngeal Neoplasms
1
Neoplasms, Unknown Primary
1
Neoplasms, Squamous Cell
1
Neoplasms, Basal Cell
1
Neoplasm Metastasis
1
Multiple Myeloma
1
Mouth Neoplasms
1
Melanoma
1
Lymphoma, Non-Hodgkin
1
Locally Advanced or Metastatic EGFR Sensitising Mutation Positive Non Small Cell Lung Cancer
1
Liver Cirrhosis
1
Leiomyosarcoma
1
Laryngeal Neoplasms
1
Kidney Neoplasms
1
Hypopharyngeal Neoplasms
1
Histiocytoma, Malignant Fibrous
1
Hereditary leiomyomatosis and renal cell cancer
1
Interventions
Specimen Handling
3
Nivolumab
3
Magnetic Resonance Spectroscopy
3
Biopsy
3
Fluorouracil
2
Etoposide
2
Cyclophosphamide
2
liposomal doxorubicin
1
fludarabine
1
dehydroftorafur
1
carmustine, poliferprosan 20 drug combination
1
cabozantinib
1
axicabtagene ciloleucel
1
Zidovudine
1
X-Rays
1
Vincristine
1
Valganciclovir
1
Triage
1
Therapeutics
1
Standard of Care
1
Sodium Chloride
1
Smoking Devices
1
Sirolimus
1
Sigmoidoscopy
1
Sentinel Lymph Node Biopsy
1
Rituximab
1
Restraint, Physical
1
Raltegravir Potassium
1
Radiotherapy, Intensity-Modulated
1
Proctoscopy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
HIV Infections
×
Erlotinib Hydrochloride
×
1 year
×
Clear all
No trials found.